Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Can’t see the forest through the trees.
IDE submittal Q1, human clinical trials Q2.
Just did a video of a live pig not chicken breast. When you say things like this you expose yourself do better next time or you’ll never get this down to $1.18.
Worst shorts Eva…..Well…..We’re waiting!!!
Well…..we’re waiting!!!!!
Thanks for sharing your thoughts Belize me. Food for thought. I’m not sure I agree but I also know that I don’t know what they are developing. My guess is it’s not for current Hugo. They didn’t have enough time to implement and gain FDA submission and approvals with current timeline and believe they will probably use some of the clinical trial data they have from other countries for FDA. Good points on the value or lack there of in having all the robots. That being said, it certainly helps to have all the robotic offerings that the market leader (intuitive) has as well as the complementary portfolio that a Medtronic has.
It may be that it allows them to kick the tires on Enos as you stated below. The development agreement calls for a prototype of some sort to be delivered by Titan though so what could that be for? My guess is that Medtronic wanted some other functionality incoporated into Enos or there could be something to Rocko contention that they are helping with some type of Endoluminal offering. Could it be something under development at Medtronic or perhaps from another private company that Medtronic is working with? The two things that don’t add up for me is medtronic being given access to Titans BOD meetings if it is just to acquire some IP via licensing for their own needs. The other thing that is very odd is Sachin Sankholar going to Medtronic during this partnership. How can they be stealing Titans talent. No non compete? Wouldn’t this muddy the waters if they were going to run with some licensed IP from Titan without a deeper relationship?
Prove it
It’s not IREP was not patentable. Can’t wait to see how other companies in the space respond to the lighting that Titan has developed.
You seem like a veteran business exec. What do you think they are making for Medtronic?
Those options were already budgeted. Remember you voted for them…. Or maybe you didn’t.
All the longs harvested a long time ago and shorts are in the money. Sorry charlie
The big short? C’mon man! The shorts have no juice these days.
We’re……
Waiting
Well
We’re waiting……..
All longs tax harvested a long time ago. Major miscalculation. Well…..we’re waiting!!
All good points. We won’t know until we know what the redacted language says. Think it’s a good thing. Should have some clarification after milestone 4.
Nope they did it through revenue created by a strategic partnerships with Medtronic. I guess you haven’t been following recent developments.
“The truly outstanding thing is that the company has managed to keep itself afloat all of these many years. And like countless other penny stocks, it does so through the magic of DILUTION......as the managers endlessly dilute the shares out of 98% of their money over time.
Fortunately, there was one guy who got conned who bought at 4 bucks and lost 35 grand and then came back and took this stock blind for several hundred thousand smackers. ....and this means that the bad guys do not always win. “
Here’s a trend for you. The most successful hedge fund in the world has a sizable position.
Neither did McNally. He signed a development agreement for 41 million. Surely you know that??
Leon wasn’t around in 2016
Prove it
Thanks for sharing and to answer your question - No I don’t believe so.
Bleeding? I’ve been waiting for weeks for $1.20 and the shorts can’t make it happen.
Ladies and Gentlemen, it looks like el presidente has joined our ranks. Stocks only go up!
Well.......we’re waiting!
Jojo is correct. They changed the strike price but didn’t change the shares. Accounting error on Titans part
Long way from $1.20 #fail
I know I’m waiting. You shorts were handed a gift and can’t do anything about it. C’mon man!
By the time they are at 30 Titan will be at 250 and FDA approved.
Did JNJ buy it for it’s hardware? You just said it has no platform and no software.... so what did they buy?
Verb surgical has 97 patents vicarious 4. And No, one of them isn’t IREP. That was unpatentable and discarded years ago.
Unlike you I never bought into the Verb hype…I always said it was just that.. hype..
All the while you saying Titan was running the Verb OS…if there even was such a thing….
Verb had nothing but you bought into it…
Vicarious has a platform that the FDA gave Breakthrough Device designation.
No hype at Vicarious…a real platform that the FDA wants to get approved quickly.
Legends in surgical robotics running the show…
Last thing Titan needs right now is a far more capable SP platform heading for FDA approval and guaranteed CMS reimbursement on day 1 of approval.
Bottom line this isn’t Verb and Verbs latte siping millennials sitting around at meetings asking themselves “am I a Verb?” LOL
Those people know to have any value they’d have to split. Who you foolin
Exactly
Post 129615
Anyone hoping to "hedge" their short position or a long wishing to sell now to "tax loss harvest" better multiply their warrants they hope to convert to shares by 30. Anyone that THINKS would ask their broker how many warrants it takes to convert to 1 share . I'll give you a hint... its 30.
So for math experts, here is the actual math
10,000 shares
/ 30
_______
333 shares
X $5 profit
_________
$1,665 wooooot!
On the other hand, if one took that $130 and bought shares at $1.70, they would have 76 shares x $22.96 b.o. price gives you $1,775. Without the risk of warrants expiring worthless.
#THINK
REALITY
Not true. Look in the official filings.... but you already knew that.
Titan has zero problems raising money, and now they don’t have to
Prove it
Soft rollout into a few key hospitals and the money will be there with proof of concept. This is a lucrative business and big money will want in
Adrock is this the patent for the off the shelf endoscope Medtronic was licensing from Titan.